Navigation Links
Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets
Date:12/2/2009

79 C.R. BARD PATENTS BY LIFE CYCLE (NUMBER) 136

TABLE 80 C.R. BARD PATENTS BY INVENTION TYPE (NUMBER) 136

CARDIMA, INC. 137

CARDIMA PATENTS 137

TABLE 81 CARDIMA PATENTS BY COUNTRY (NUMBER) 137

TABLE 82 CARDIMA PATENTS BY PUBLICATION YEAR, 1998-2000 (NUMBER) 138

TABLE 83 CARDIMA PATENTS BY LIFE CYCLE (NUMBER) 138

TABLE 84 CARDIMA PATENTS BY INVENTION TYPE (NUMBER) 138

COOK MEDICAL, INC. 139

COOK MEDICAL PATENTS 139

TABLE 85 COOK MEDICAL PATENTS BY COUNTRY (NUMBER) 139

TABLE 86 COOK MEDICAL PATENTS BY PUBLICATION YEAR, 1994-2009 (NUMBER) 139

TABLE 87 COOK MEDICAL PATENTS BY LIFE CYCLE (NUMBER) 140

TABLE 88 COOK MEDICAL PATENTS BY INVENTION TYPE (NUMBER) 140

CORDIS CORP. 141

CORDIS PATENTS 141

TABLE 89 CORDIS PATENTS BY COUNTRY (NUMBER) 141

TABLE 90 CORDIS PATENTS BY PUBLICATION YEAR, 1974-2008 (NUMBER) 142

TABLE 91 CORDIS PATENTS BY LIFE CYCLE (NUMBER) 142

TABLE 92 CORDIS PATENTS BY INVENTION TYPE (NUMBER) 143

CRYOCATH TECHNOLOGIES, INC. 144

CRYOCATH PATENTS 144

TABLE 93 CRYOCATH PATENTS BY COUNTRY (NUMBER) 144

TABLE 94 CRYOCATH PATENTS BY PUBLICATION YEAR, 1988-2008 (NUMBER) 145

TABLE 95 CRYOCATH PATENTS BY LIFE CYCLE (NUMBER) 145

TABLE 96 CRYOCATH PATENTS BY INVENTION TYPE (NUMBER) 145

DATASCOPE CORP. 146

DATASCOPE PATENTS 147

TABLE 97 DATASCOPE PATENTS BY COUNTRY (NUMBER) 147

TABLE 98 DATASCOPE PATENTS BY PUBLICATION YEAR, 1976-2009 (NUMBER) 147

TABLE 99 DATASCOPE PATENTS BY LIFE CYCLE (NUMBER) 148

TABLE 100 DATASCOPE PATENTS BY INVENTION TYPE (NUMBER) 148

EDWARDS LIFESCIENCES CORP. 149

EDWARDS LIFESCIENCES PATENTS 149

TABLE 101 EDWARDS LIFESCIENCES PATENTS BY COUNTRY (NUMBER) 149

TABLE
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Reportlinker Adds Chiral Technology - International Technology & Market Trends
2. Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends
3. Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends
4. Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis
5. Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities
6. Reportlinker Adds Global Markets for Asthma and COPD Drugs
7. Reportlinker Adds Insulin Pumps (External) - A World Market Review
8. Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities
9. Reportlinker Adds HPLC Systems & Accessories - A World Market Review
10. Reportlinker Adds Molecular Diagnostics - A World Market Review
11. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014   Regulus Therapeutics Inc ... company leading the discovery and development of innovative ... its ATHENA natural history of disease study in ... disease with no approved therapy. The ATHENA study ... renal function markers such as Glomerular Filtration Rate ...
(Date:9/18/2014)... and ROCKVILLE, Md. , ... SPPI ), a biotechnology company with fully integrated ... in hematology and oncology, and CASI Pharmaceuticals, Inc. (Nasdaq: ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a primary focus on China ...
(Date:9/18/2014)... Sept. 18, 2014  RXi Pharmaceuticals Corporation ... company focused on discovering, developing and commercializing ... using RNA-targeted technologies, today announced that the Company,s ... Geert Cauwenbergh , will present at the ... on Wednesday, September 24, 2014 at 11:20 ...
Breaking Medicine Technology:Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 3Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 4Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 5Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 7Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 8Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 9Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 10RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3
... 2011 On Sunday, August 21, veterinary cardiologists are ... the Mobile Dog Heart Health Tour will stop with ... examinations at Peters Park Dog Run. (Photo: ... free heart health screenings, veterinarians will be available to ...
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... it has finalized a previously disclosed Equipment Financing ... $10 million in available funding. This agreement will ... finance the automated assembly line now manufacturing the ...
Cached Medicine Technology:Free Dog Heart Health Screenings Available August 21 in Boston 2Unilife Signs $10 Million Equipment Financing Agreement 2Unilife Signs $10 Million Equipment Financing Agreement 3Unilife Signs $10 Million Equipment Financing Agreement 4
(Date:9/18/2014)... Qualis Health, one of the nation’s leading population ... “Advancing Primary Care through the Patient-Centered Medical Home Model ... Jeff Hummel, MD, MPH and Peggy C. Evans, PhD, ... the work of becoming a Patient-Centered Medical Home (PCMH) ... such as generating and providing useful data that can ...
(Date:9/18/2014)... developed a new method to study Ebola virus in ... Conservation Society (WCS)-led research, published today in the journal ... of fecal samples from wild great apes to identify ... This represents a new tool for performing large, population-scale ... virus is studied and improve our understanding of the ...
(Date:9/18/2014)... recommending that elderly men should not be routinely screened ... to a new study led by researchers at Henry ... online in JAMA Internal Medicine , focused on ... test for prostate cancer., "We found that the effect ... elderly men in particular has been minimal at best," ...
(Date:9/18/2014)... 2014 With the swift industrial development ... such as smart phones, tablets and PDAs, a complete ... mobile devices are viewed these days. From only being ... becoming a mode for creating and delivering content while ... way. , The complete makeover of this ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 A sold-out ... community advocates, and volunteers supported United Way of ... Chefs and Fine Wines” event Monday, Sept. 15. Proceeds ... health initiatives in Westchester and Putnam, such as providing ... steering teens away from risky behaviors like drug and ...
Breaking Medicine News(10 mins):Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:Professional recommendations against routine prostate cancer screening have little effect 2Health News:Transparency Market Research: M-health Market Study 2018 2Health News:Transparency Market Research: M-health Market Study 2018 3Health News:Transparency Market Research: M-health Market Study 2018 4Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3
... people who have optic nerve damage might be at ... the study researchers involved 25 people with visual impairment. ... days, and their results were compared with those of ... that those with optic nerve disease were 20-times more ...
... inflammation of the liver and can cause complications such ... the hepatitis B vaccine is recommended for infants. Previous ... against infection for up to 10 years. However, a ... 10 years. ,Researchers followed eight-hundred-and-forty-one Alaska natives vaccinated ...
... of the expectant mother. Now a new study suggests ... of preeclampsia in the pregnant women. ,The ... with periodontitis with atherosclerosis to preeclampsia. Such an oral ... abuse like smoking, etc. The basic reason for setting ...
... and vitamin B12 are safe and effective in reducing the ... a stroke . According to researchers stroke patients have a ... healthy peers due to higher levels of plasma homocysteine in ... of hip fracture. ,The study was initiated to ...
... in Japan, even after the country has banned the shots of ... of the must-have vaccines to be given to children before they ... journal Lancet in 1998 had published a paper relating the MMR ... there had been considerable fall in vaccinating children with MMR (Measles, ...
... benefits of alcohol consumption and cardiovascular disease researchers studied ... // moderate levels of alcohol (one to seven drinks ... eight drinks per week), and did not consume any ... first to focus on the association between alcohol intake ...
Cached Medicine News:
Caspar Curette, 250 mm, 10"....
Bone Curette, 160 mm...
Bone Curette, 145 mm...
Bone Currettes...
Medicine Products: